Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Normal opioid tone and hypothalamic–pituitary–adrenal axis function in chronic fatigue syndrome despite marked functional impairment.

Tytuł:
Normal opioid tone and hypothalamic–pituitary–adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
Autorzy:
Inder, Warrick J.
Prickett, Timothy C. R.
Mulder, Roger T.
Temat:
CHRONIC fatigue syndrome
CHRONIC diseases
HYPOTHALAMIC-pituitary-adrenal axis
OPIOIDS
ADRENOCORTICOTROPIC hormone
PEPTIDE hormones
NEUROENDOCRINOLOGY
Źródło:
Clinical Endocrinology; Mar2005, Vol. 62 Issue 3, p343-348, 6p
Czasopismo naukowe
To determine whether the functional impairment seen in chronic fatigue syndrome (CFS) is associated with reduced levels of central opioids and/or deficiency of the hypothalamic–pituitary–adrenal (HPA) axis.Single-blinded case–control study measuring functional and psychological status, basal hormonal parameters and ACTH/cortisol response to naloxone and ovine corticotrophin-releasing hormone (oCRH)vs.placebo in people with CFS and healthy controls.Twelve people with CFS and 11 age-matched controls.Hormonal parameters: basal levels of 09:00 h plasma cortisol, dehydroepiandrosterone sulfate (DHEAS) and IGF-1. 24-h urinary free cortisol. Plasma ACTH and cortisol response to naloxone 125 µg/kg, oCRH 1 µg/kg and placebo (normal saline). Psychological parameters: SF-36, Hamilton Depression Score, Hospital Anxiety and Depression Scale and Fatigue Scale.There were highly significant differences between the CFS subjects and the controls with respect to the measures of fatigue and physical functioning. However, there were no differences in basal levels of 09:00 h cortisol (367 ± 37vs.331 ± 39 nmol/l,P = 0·51), DHEAS (4·2 ± 0·6vs.4·0 ± 0·5 µmol/l,P = 0·81), 24-h urinary free cortisol (182 ± 27vs.178 ± 21 nmol/24 h,P = 0·91) or IGF-1 (145 ± 19vs.130 ± 11 µg/l,P = 0·52) between the CFS group and controls, respectively. There was also no difference between the groups with respect to the ACTH and cortisol response to either oCRH or naloxone.Our data do not support an aetiological role for deficiency in central opioids or the HPA axis in the symptoms of CFS. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Endocrinology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies